Squarepoint’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-109,485
| Closed | -$407K | – | 2977 |
|
2024
Q3 | $407K | Buy |
109,485
+48,549
| +80% | +$181K | ﹤0.01% | 1865 |
|
2024
Q2 | $385K | Buy |
+60,936
| New | +$385K | ﹤0.01% | 1846 |
|
2024
Q1 | – | Sell |
-55,322
| Closed | -$278K | – | 2643 |
|
2023
Q4 | $278K | Buy |
+55,322
| New | +$278K | ﹤0.01% | 1992 |
|
2023
Q2 | – | Sell |
-481,915
| Closed | -$877K | – | 2587 |
|
2023
Q1 | $877K | Buy |
+481,915
| New | +$877K | ﹤0.01% | 1231 |
|
2022
Q3 | – | Sell |
-26,500
| Closed | -$99K | – | 2275 |
|
2022
Q2 | $99K | Sell |
26,500
-16,891
| -39% | -$63.1K | ﹤0.01% | 1874 |
|
2022
Q1 | $243K | Sell |
43,391
-16,814
| -28% | -$94.2K | ﹤0.01% | 1830 |
|
2021
Q4 | $366K | Buy |
+60,205
| New | +$366K | ﹤0.01% | 1774 |
|
2021
Q3 | – | Sell |
-62,550
| Closed | -$893K | – | 2469 |
|
2021
Q2 | $893K | Buy |
62,550
+50,050
| +400% | +$715K | ﹤0.01% | 1253 |
|
2021
Q1 | $297K | Buy |
+12,500
| New | +$297K | ﹤0.01% | 1885 |
|
2020
Q4 | – | Sell |
-38,571
| Closed | -$267K | – | 2680 |
|
2020
Q3 | $267K | Buy |
38,571
+26,194
| +212% | +$181K | ﹤0.01% | 1755 |
|
2020
Q2 | $152K | Sell |
12,377
-1,093
| -8% | -$13.4K | ﹤0.01% | 1836 |
|
2020
Q1 | $39K | Buy |
+13,470
| New | +$39K | ﹤0.01% | 1732 |
|
2018
Q4 | – | Sell |
-10,383
| Closed | -$38K | – | 2056 |
|
2018
Q3 | $38K | Sell |
10,383
-13,892
| -57% | -$50.8K | ﹤0.01% | 1921 |
|
2018
Q2 | $74K | Buy |
+24,275
| New | +$74K | ﹤0.01% | 1668 |
|
2016
Q1 | – | Sell |
-10,100
| Closed | -$175K | – | 1293 |
|
2015
Q4 | $175K | Buy |
+10,100
| New | +$175K | 0.02% | 1035 |
|